Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical applications of next-generation sequencing-based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression.
Klocker EV, Hasenleithner S, Bartsch R, Gampenrieder SP, Egle D, Singer CF, Rinnerthaler G, Hubalek M, Schmitz K, Bago-Horvath Z, Petzer A, Heibl S, Heitzer E, Balic M, Gnant M. Klocker EV, et al. Among authors: hubalek m. Mol Oncol. 2024 Jun 12. doi: 10.1002/1878-0261.13671. Online ahead of print. Mol Oncol. 2024. PMID: 38867388 Free article. Review.
Development and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of tamoxifen, anastrozole, and letrozole in human plasma and its application to a clinical study.
Beer B, Schubert B, Oberguggenberger A, Meraner V, Hubalek M, Oberacher H. Beer B, et al. Among authors: hubalek m. Anal Bioanal Chem. 2010 Oct;398(4):1791-800. doi: 10.1007/s00216-010-4075-z. Epub 2010 Aug 22. Anal Bioanal Chem. 2010. PMID: 20730580
Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs).
Oberguggenberger A, Hubalek M, Sztankay M, Meraner V, Beer B, Oberacher H, Giesinger J, Kemmler G, Egle D, Gamper EM, Sperner-Unterweger B, Holzner B. Oberguggenberger A, et al. Among authors: hubalek m. Breast Cancer Res Treat. 2011 Jul;128(2):553-61. doi: 10.1007/s10549-011-1378-5. Epub 2011 Feb 11. Breast Cancer Res Treat. 2011. PMID: 21311968
Adherence evaluation of endocrine treatment in breast cancer: methodological aspects.
Oberguggenberger AS, Sztankay M, Beer B, Schubert B, Meraner V, Oberacher H, Kemmler G, Giesinger J, Gamper E, Sperner-Unterweger B, Marth C, Holzner B, Hubalek M. Oberguggenberger AS, et al. Among authors: hubalek m. BMC Cancer. 2012 Oct 15;12:474. doi: 10.1186/1471-2407-12-474. BMC Cancer. 2012. PMID: 23066928 Free PMC article.
The vitamin E-binding protein afamin increases in maternal serum during pregnancy.
Hubalek M, Buchner H, Mörtl MG, Schlembach D, Huppertz B, Firulovic B, Köhler W, Hafner E, Dieplinger B, Wildt L, Dieplinger H. Hubalek M, et al. Clin Chim Acta. 2014 Jul 1;434(100):41-7. doi: 10.1016/j.cca.2014.03.036. Epub 2014 Apr 24. Clin Chim Acta. 2014. PMID: 24768783 Free PMC article.
Getting the whole picture: adding patient-reported outcomes to adjuvant endocrine treatment evaluation in premenopausal breast cancer patients.
Oberguggenberger A, Goebel G, Beer B, Oberacher H, Meraner V, Sztankay M, Sperner-Unterweger B, Zeimet AG, Marth C, Hubalek M, Holzner B. Oberguggenberger A, et al. Among authors: hubalek m. Breast J. 2014 Sep-Oct;20(5):555-7. doi: 10.1111/tbj.12323. Epub 2014 Jul 8. Breast J. 2014. PMID: 25040193 No abstract available.
143 results